GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Respiratorius AB (XSAT:RESP) » Definitions » Interest Coverage

Respiratorius AB (XSAT:RESP) Interest Coverage : No Debt (1) (As of Dec. 2023)


View and export this data going back to 2012. Start your Free Trial

What is Respiratorius AB Interest Coverage?

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Respiratorius AB's Operating Income for the three months ended in Dec. 2023 was kr-2.46 Mil. Respiratorius AB's Interest Expense for the three months ended in Dec. 2023 was kr0.00 Mil. Respiratorius AB has no debt. The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Respiratorius AB has no debt.

(1) Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

The historical rank and industry rank for Respiratorius AB's Interest Coverage or its related term are showing as below:

XSAT:RESP' s Interest Coverage Range Over the Past 10 Years
Min: No Debt   Med: No Debt   Max: No Debt
Current: No Debt


XSAT:RESP's Interest Coverage is ranked better than
99.42% of 345 companies
in the Biotechnology industry
Industry Median: 144.99 vs XSAT:RESP: No Debt

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Respiratorius AB Interest Coverage Historical Data

The historical data trend for Respiratorius AB's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Respiratorius AB Interest Coverage Chart

Respiratorius AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Interest Coverage
Get a 7-Day Free Trial Premium Member Only Premium Member Only No Debt - - No Debt -

Respiratorius AB Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Apr22 Sep22 Mar23 Jun23 Sep23 Dec23
Interest Coverage Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only No Debt No Debt No Debt No Debt No Debt

Competitive Comparison of Respiratorius AB's Interest Coverage

For the Biotechnology subindustry, Respiratorius AB's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Respiratorius AB's Interest Coverage Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Respiratorius AB's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Respiratorius AB's Interest Coverage falls into.



Respiratorius AB Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage=-1* Operating Income /Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt (1).


Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Respiratorius AB's Interest Coverage for the fiscal year that ended in Dec. 2023 is calculated as

Here, for the fiscal year that ended in Dec. 2023, Respiratorius AB's Interest Expense was kr-0.00 Mil. Its Operating Income was kr-7.83 Mil. And its Long-Term Debt & Capital Lease Obligation was kr0.00 Mil.

Respiratorius AB did not have earnings to cover the interest expense.

Respiratorius AB's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Here, for the three months ended in Dec. 2023, Respiratorius AB's Interest Expense was kr0.00 Mil. Its Operating Income was kr-2.46 Mil. And its Long-Term Debt & Capital Lease Obligation was kr0.00 Mil.

Respiratorius AB had no debt (1).

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.


Respiratorius AB  (XSAT:RESP) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .


Respiratorius AB Interest Coverage Related Terms

Thank you for viewing the detailed overview of Respiratorius AB's Interest Coverage provided by GuruFocus.com. Please click on the following links to see related term pages.


Respiratorius AB (XSAT:RESP) Business Description

Traded in Other Exchanges
Address
Scheelevagen 2, Medicon Village, Lund, SWE, 223 81
Respiratorius AB develops pharmaceutical drugs to treat the common diseases namely Cancer, Chronic Obstructive Pulmonary Disease (COPD), and asthma as well as better methods for diagnosing cardiovascular diseases. The company's drug candidates includes RCD405, VAL001, RESP2000, RESP3000, RESP9000, and RESP1000.

Respiratorius AB (XSAT:RESP) Headlines

No Headlines